Evidence map›Paper›PMID 26427614›Full record

ArticlePlant biotechnology journal2016

Creation of the first ultra-low gluten barley (Hordeum vulgare L.) for coeliac and gluten-intolerant populations.

Gregory J Tanner, Malcolm J Blundell, Michelle L Colgrave, Crispin A Howitt

Abstract read
In one paragraph

Article in Plant biotechnology journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Proteome Changes Resulting from Malting in Hordein-Reduced Barley Lines.Journal of agricultural and food chemistry · 2023
    Article
  6. Article
  7. Article
  8. Review
  9. Application of Mass Spectrometry-Based Proteomics to Barley Research.Journal of agricultural and food chemistry · 2021
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Celiac Antigenicity of Ancient Wheat Species.Foods (Basel, Switzerland) · 2019
    Article
  18. Article
  19. Article
  20. Hordein Accumulation in Developing Barley Grains.Frontiers in plant science · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Gregory J TannerCSIRO Agriculture Flagship, Canberra, ACT, Australia.
Malcolm J BlundellCSIRO Agriculture Flagship, Canberra, ACT, Australia.
Michelle L ColgraveCSIRO Agriculture Flagship, St Lucia, Qld, Australia.
Crispin A HowittCSIRO Agriculture Flagship, Canberra, ACT, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coeliac disease is a well-defined condition that is estimated to affect approximately 1% of the population worldwide. Noncoeliac gluten sensitivity is a condition that is less well defined, but is estimated to affect up to 10% of the population, and is often self-diagnosed. At present, the only remedy for both conditions is a lifelong gluten-free diet. A gluten-free diet is often expensive, high in fat and low in fibre, which in themselves can lead to adverse health outcomes. Thus, there is an opportunity to use novel plant breeding strategies to develop alternative gluten-free grains. In this work, we describe the breeding and characterization of a novel ultra-low gluten (ULG) barley variety in which the hordein (gluten) content was reduced to below 5 ppm. This was achieved using traditional breeding strategies to combine three recessive alleles, which act independently of each other to lower the hordein content in the parental varieties. The grain of the initial variety was shrunken compared to wild-type barleys. We implemented a breeding strategy to improve the grain size to near wild-type levels and demonstrated that the grains can be malted and brewed successfully. The ULG barley has the potential to provide novel healthy foods and beverages for those who require a gluten-free diet.

Indexed as

AcrylamideAmino AcidsAmylasesCeliac DiseaseDiet, Gluten-FreeEnzyme-Linked Immunosorbent AssayFlourGlutensHordeumHumansMass SpectrometryPlant BreedingSeedsAcrylamideAmino AcidsAmylasesGlutensbarleycoeliac diseasegluten-freegluten-intolerancehordeinHordeum vulgare

Identifiers

PMID26427614
PMCPMC5054857

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.